CardioPolymers Raises $13.57

Laguna Hills-based CardioPolymers, which is developing an implantable device for treating congestive heart failure, has raised $13.57M in a funding round, according to a regulatory filing by the firm today. The filing puts the target amount for the round at 16.2M. No details have been released by the company, which has previously raised funding from Domain Associates, Morgenthaler Ventures, Johnson & Johnson Development Corporation, Triathlon Medical Ventures, Saints Capital, and Fjord Ventures. More information »